Neal Bhatia, MD: Topical Therapies Pipeline

Dr. Neal Bhatia reviews promising topical therapies in development, highlighting new mechanisms and formulations shaping the future of dermatologic care.

Topics Covered:

  • Emerging topical therapies in dermatology
  • Novel mechanisms of action and ingredients
  • Future trends in topical treatment development
  • Pipeline highlights for inflammatory and chronic skin diseases

 

Explore Related Resources:

Topical Therapies for the Treatment of Atopic Dermatitis

Evaluating Effective Topical Therapies for Atopic Dermatitis

MORE COVERAGE FROM THE 2025 AAD INNOVATION ACADEMY MEETING

Peter Lio, MD: Updates in AD and Diet

Dr. Lio discusses the complex relationship between diet and **Atopic Dermatitis (AD), addressing common patient questions, misconceptions, and concerns regarding dietary modifications. His presentation emphasizes

Emmy Graber, MD: New Efficacy Evidence for Acne and Rosacea Devices

Dr. Graber reviews emerging evidence supporting the use of energy-based devices for the treatment of Acne Vulgaris and Rosacea, highlighting how advances in laser and

Steve Daveluy, MD: Using Cryoinsufflation in Patients with Hidradenitis Suppurativa

Dr. Daveluy discusses practical techniques and clinical considerations for using cryoinsufflation in the treatment of Hidradenitis Suppurativa (HS). His presentation provides guidance on incorporating this

Christopher Bunick, MD, PhD: Clearing Up Questions Around Benzene in Benzoyl Peroxide Products

Dr. Bunick examines the ongoing discussion surrounding benzene contamination concerns in benzoyl peroxide (BPO) products, addressing questions about product safety, regulatory oversight, and best practices

Christopher Bunick, MD, PhD: Antibiotic Update for Acne and Rosacea

Dr. Bunick provides a comprehensive review of the evolving role of antibiotics in treating Acne Vulgaris and Rosacea, examining current evidence on their benefits, limitations,

Lisa Swanson, MD: What’s New in Pediatric Dermatology at AAD 2025

Dr. Swanson highlights key developments presented at the AAD 2025 Annual Meeting, providing an overview of emerging therapies, clinical research, and treatment advances across several

The AAD © Brand and Content are created by the American Academy of Dermatology “All rights reserved.” Any reproduction or republication is strictly prohibited without prior authorization.

The content of the 2025 AAD Innovation Academy Meeting (the “Content”) is copyrighted by the American Academy of Dermatology (“AAD”). The Works, JCADTV Coverage from the 2025 AAD Innovation Academy Meeting, are made up of coverage interviews and summaries and are created from the Content of the AAD under a license between the AAD and Matrix Medical Communications (“MATRIX MEDICAL COMMUNICATIONS”), and MATRIX MEDICAL COMMUNICATIONS is solely responsible for their content. The license of any content by the AAD does not constitute or imply endorsement of any company or its goods, services, or written work products, and the AAD is not responsible for any errors or omissions in the translation or reproduction of the content.